SCAP deficiency facilitates obesity and insulin resistance through shifting adipose tissue macrophage polarization.

Overall, the activation of the SCAP-SREBP-1a pathway in macrophages may provide a novel therapeutic strategy that ameliorates obesity by controlling cholesterol homeostasis in ATMs.